Plain-English translation of NCT07073820 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a continuation study for people who have already tried in an earlier clinical trial. Researchers want to learn more about how safe and effective this medication is when people take it over a longer period of time. The study will track how the medication works for treating pulmonary arterial hypertension, a condition where high blood pressure in the lung arteries makes it harder for your heart to pump blood.
An earlier trial showed promise with this medication, and now doctors need to understand whether it remains safe and effective over months or years of use. This longer-term data will help determine if the medication is truly helpful for people living with lung high blood pressure.
You likely qualify if…
You likely don't qualify if…
You will receive an injection of the medication under the skin once every 4 weeks. You'll attend regular study visits to have your heart and lung function checked, provide blood samples, and discuss how you're feeling and any side effects. The study is open-label, meaning both you and your doctor will know you're receiving the active medication, and you'll continue this treatment for as long as it appears safe and beneficial.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States